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Abstract
Background: Cancer is a complex disease. So far, many genes have been reported to involve in the development
of cancer. Rather than the traditional approach to studying individual genes or loci, a systematic investigation of
cancer proteins in the human protein-protein interaction network may provide important biological information for
uncovering the molecular mechanisms of cancer and, potentially, other complex diseases.
Results: We explored global and local network characteristics of the proteins encoded by cancer genes (cancer
proteins) in the human interactome. We found that the network topology of the cancer proteins was much
different from that of the proteins encoded by essential genes (essential proteins) or control genes (control
proteins). Relative to the essential proteins or control proteins, cancer proteins tended to have higher degree,
higher betweenness, shorter shortest-path distance, and weaker clustering coefficient in the human interactome.
We further separated the cancer proteins into two groups (recessive and dominant cancer proteins) and compared
their topological features. Recessive cancer proteins had higher betweenness than dominant cancer proteins, while
their degree distribution and characteristic shortest path distance were also significantly different. Finally, we found
that cancer proteins were not randomly distributed in the human interactome and they connected strongly with
each other.
Conclusion: Our study revealed much stronger protein-protein interaction characteristics of cancer proteins relative
to the essential proteins or control proteins in the whole human interactome. We also found stronger network
characteristics of recessive than dominant cancer proteins. The results are helpful for cancer candidate gene
prioritization and verification, biomarker discovery, and, ultimately, understanding the etiology of cancer at the
systems biological level.
Background
Cancer is a common complex disease. Many genetic fac-
tors and genes have been reported to play an important
role in its pathogenesis. Identification of genes that acti-
vate or accelerate the development of cancer (referred
as ‘cancer genes’) has been one of the major goals in
cancer research. During the past three decades, a great
number of cancer genes have been reported. Recently, a
census of human cancer genes was conducted based on
the published literature [1] and the annotated genes
were stored in the Cancer Gene Census database [2].
Although this collection of genes is still likely incom-
plete or error-prone, it offers us a great opportunity to
examine the general features of many cancer genes,
rather than individual gene, at one time. Indeed, several
important features have been found based on these
genes, such as sequence alteration, mutations in differ-
ent cancers, protein domains and partial network prop-
erties [1,3].
Recently, investigation of interactions between pro-
teins encoded by disease genes in the human protein-
protein interaction network (i.e., the human
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approaches to elucidating the molecular mechanisms
underlying the complex diseases [4-10]. Cancer is the
most severe human disease, costing us many billions of
dollars each year. Thus, a systematic examination of the
proteins encoded by cancer genes (cancer proteins) in
the human interactome may help us identify new candi-
date genes, improve candidate gene prioritization meth-
ods, and have a deeper understanding of the genetic
landscape of cancer. This research topic emerged
recently. For example, we have seen recent reports on
the exploration of cancer related networks including the
topological analysis [3,11], prediction of cancer candi-
date genes [12] and their dynamic modularity [13].
Meanwhile, several studies reported that essential genes
tended to encode hubs [14,15], but another study
revealed that vast majority of disease genes are nones-
sential and have no tendency toward higher degree in
the human protein-protein interaction network. Such
incongruence of disease and essential gene properties in
the human interactome requires further investigations.
Moreover, so far these studies have explored only lim-
ited network properties or focused on one specific type
of cancers. To have a global view of the interactions of
cancer proteins, it is necessary to systematically investi-
gate the network properties of cancer proteins in the
human interactome, to compare properties of the sub-
types of cancer proteins, and also to compare cancer
proteins with essential proteins.
In this study, we explored the global and local net-
work characteristics of cancer proteins through mapping
the cancer proteins into the human interactome. For the
global properties, we performed four different topologi-
cal measurements, i.e., degree, betweenness, clustering
coefficient and shortest-path distance. To assess the
observed topological features of cancer proteins, we
compared them to other proteins encoded by essential
genes (essential proteins) or control genes (control pro-
teins). For local network characteristics, we extracted
subnetworks for the cancer proteins and compared
them with the randomly generated networks. Our
results revealed that (1) cancer proteins display a global
topology that is significantly different from that of
essential proteins or control proteins, (2) cancer proteins
could form non-random networks, and (3) recessive
cancer proteins had even stronger network characteris-
tics than dominant cancer proteins.
Methods
Construction of the human interactome
Investigation of the protein interaction characteristics for
a set of proteins requires a complete and accurate whole
protein interaction network. In this study, we integrated
all the available human protein-protein interactions from
six major protein interaction databases but restricted
only those with experimental evidence. The six databases
are Human Protein Reference Database (HPRD, release
7) [16], Biomolecular Interaction Network Database
(BIND, 20060525) [17] , IntAct (downloaded on 2007-
09-28) [18], Molecular INTeration database (MINT,
downloaded on 2007-06-28) [19], Reactome (version 24)
[20] and the Database of Interacting Proteins (DIP, ver-
sion Hsapi20070707) [21]. After removing the redun-
dancy and self-interactions, we constructed a
comprehensive and reliable human protein-protein inter-
action network, which contained 53,255 unique interac-
tions among 10,549 proteins. We considered these
interactions as an approximation of a full set of human
protein-protein interactions, or, the human interactome.
Cancer genes, essential genes and control genes
We obtained 384 cancer genes and their detailed anno-
tations from the Cancer Gene Census database (2009-
08-04 version) [2]. The Cancer Gene Census database is
updated regularly based on the original census data
summarized in Nature Review Cancer [1]. Among the
384 cancer genes, 382 could be mapped to genes with
official gene symbols in the National Center for Biotech-
nology Information (NCBI) [22]. We considered these
genes as cancer candidate genes. Among them, there
were 342 genes whose proteins could be found in the
human interactome. A cancer gene may act in a domi-
nant or recessive manner [23]. Therefore, we separated
these 342 cancer genes into two groups: recessive group,
which had 69 cancer genes, and dominant group, which
had 273 cancer genes, according to the annotations in
the Cancer Gene Census database.
For comparison, we compiled two other gene sets:
essential genes and control genes. For essential gene set,
we used the method described in Goh et al. [7], which
considered the classes of embryonic/prenatal lethality
and postnatal lethality as lethal phenotypes and the rest
of phenotypes as non-lethal ones. We retrieved the
human-mouse orthologs and mouse phenotype data
from the Mouse Genome Informatics (downloaded on
September 5, 2008) [24,25]. There were 2217 mouse-
lethal human orthologs. We considered them as essential
genes. Among them, 1896 were mapped in the human
interactome. For control genes, we excluded the cancer
genes and essential genes from all protein-coding genes
mapped in our human interactome. This resulted in 8402
control genes. Table 1 summarizes the five gene sets and
their mapped information in the human interactome.
Global network analysis
For each node in each protein set, we applied four topo-
logical measures to assess its role in the network [26]:
degree and degree distribution, clustering coefficient,
Sun and Zhao BMC Genomics 2010, 11(Suppl 3):S5
http://www.biomedcentral.com/1471-2164/11/S3/S5
Page 2 of 10betweenness, and shortest-path distance. First, the
degree or connectivity of a node, k, is the count (num-
ber) of the direct links of this node in the network. For
a set of proteins, we plotted degree distribution for
more detailed information. Based on the distribution, we
had P(k), which is the probability that a node has exactly
k links in the set of proteins. The more links a node has,
the more important it is in terms of network stability
[27]. Second, the clustering coefficient, C, of a node is
the ratio of the observed number of direct connections
between the node’s immediate network neighbors over
the maximum possible number of such connections.
Third, the betweenness of a node, B, is defined as the
number of shortest paths between all possible pairs of
nodes in the network that traverse the node. In a biolo-
gical network, betweenness measures the ways in which
signals can pass through the interaction network [13].
Fourth, for a pair of selected nodes in the network,
there are many alternative paths between them. The
path with the smallest number of links is defined as the
shortest path. The number of links passing through in
the shortest path is defined as shortest-path distance
(L). Because the two nodes in a pair might belong to the
same protein set or to different protein sets, we
extended the shortest paths into two categories. The
first one is the shortest-path between one node belong-
ing to one protein set and another node not belonging
to that protein set. The distance was defined as the gen-
eral shortest-path distance (abbreviated as gSPD). The
second one is the shortest-path between two nodes
from the same protein set. The distance was defined as
the characteristic shortest-path distance (abbreviated as
cSPD). For a protein set, we calculated the mean value
of all proteins, i.e., average degree, average betweenness,
average clustering coefficient or average shortest-path
distance.
Construction and randomization of cancer-specific
networks
To generate cancer-specific network, we started from
the 342 cancer proteins and extracted the protein-
protein interactions between these proteins. To test
whether the observed cancer-specific networks are not
random, we applied an empirical approach. First, we
generated 1000 randomized networks with the same
number of nodes and links as in the cancer-specific net-
works using the Erdos-Renyi model [28] in R igraph
package. For each random network, we calculated the
average values for three measurements: betweenness (B),
clustering coefficient (C), and general shortest-path dis-
tance (L). Next, we counted the number of the rando-
mized networks whose average betweenness (nB)o r
clustering coefficient (nC) was higher than the observed
betweenness or clustering coefficient, respectively. For
general shortest-path distance, we counted the number
(nL) of the randomized networks whose shortest-path
distance is shorter than that of the cancer-specific net-
works. Finally, we calculated empirical P value = nB
/1000, nC/1000, or nL /1000, respectively, for these three
network topological measurements.
Functional analysis of top cancer proteins
We examined the functional features of cancer proteins
that were top ranked in network analysis. We ranked
the cancer proteins and selected the top 20 cancer pro-
teins for each network measure. This resulted in a total
of 44 cancer proteins after removing the redundancy.
We examined the biological significance of these top
genes in KEGG database by pathway enrichment analy-
sis. KEGG is a database of biological system that inte-
grates genomic, chemical and functional information
through the process of PATHWAY mapping [29].
KEGG PATHWAY database includes about 120 existing
pathways and KEGG DISEASE links disease genes, path-
ways, drugs and diagnostic markers [30]. We calculated
P values using the Fisher’s exact test using the human
genome as the background and then adjusted the P
values by FDR using Benjamini- Hochberg procedure
[31]. We applied the following two criteria to identify
cancer-enriched pathways: 1) FDR P value was less than
0.001 and 2) the number of cancer proteins involved in
a pathway was at least 5.
Table 1 Summary of network properties for five protein sets in the human interactome
Protein set No. of genes No. of proteins
a Network properties (average value)
Connectivity Betweenness (10
4) Clustering coefficient gSPD
b cSPD
c
Cancer proteins 382 342 25.41 6.29 0.13 3.63 3.20
Essential proteins 2217 1896 18.39 4.16 0.14 3.76 3.55
Control proteins 8402 8402 8.25 1.47 0.19 3.99 4.10
Recessive cancer proteins 72 69 33.03 9.82 0.13 3.61 3.05
Dominant cancer proteins 310 273 23.44 5.33 0.13 3.64 3.21
aNumber of genes whose proteins could be found in the human interactome.
bGeneral shortest-path distance between the interest proteins and the remaining proteins in thewhole network.
cCharacteristic shortest-path distance among the interest proteins in the whole network.
Sun and Zhao BMC Genomics 2010, 11(Suppl 3):S5
http://www.biomedcentral.com/1471-2164/11/S3/S5
Page 3 of 10Results and discussion
Global properties of cancer proteins
In a biological network, topological properties of nodes
are important for understanding the underlying biologi-
cal mechanisms [26]. In this study, we examined four
important network measurements: degree, betweenness,
clustering coefficient and shortest-path distance. Table 1
summarizes the global properties of the five protein sets.
Cancer proteins tend to have higher degree
The average degree of the 342 cancer proteins was
25.41, which was significantly higher than that of the
essential proteins (18.39, Wilcoxon test, P =1 . 2×1 0
–6)
or that of the control proteins (8.25, P <2 . 2×1 0
–16).
The average degree of the cancer proteins is approxi-
mately 3.1 times that of the control proteins. The ratio
is higher than that (2.1) based on the predicted protein-
protein interactions in a previous study [3]. Thus, pro-
teins encoded by cancer genes tend to interact strongly
with other proteins and have higher connectivity in the
whole network. This observation of higher degree in the
cancer proteins than the control proteins supports a
recent report that disease genes tend to have higher
degree than non-disease genes [3].
To have a more detailed view of the degree character-
istics, we plotted the degree distribution for the three
proteins sets (Figure 1). The cancer proteins tended to
skew toward higher degree than the essential proteins or
control proteins (cancer vs. essential proteins, P = 1.1 ×
10
–11; cancer vs. control proteins, P <2 . 2×1 0
–16,
Wilcoxon test). Highly connected nodes are usually
defined as “hubs”.A tp r e s e n t ,d e f i n i t i o no fh u b si ss t i l l
an unsolved issue in biological network analysis. We
applied two cutoffs (degree >5 and degree >12) to define
hubs in this study. The first cutoff ( degree >5) is the
traditional definition of hubs in the protein interaction
network [13]. According to this cutoff, there were 250
(73.1%) of the cancer proteins classified into hubs,
which is significantly higher than that of the essential
proteins (61.4%, c
2 test, P =4 . 7×1 0
–5)o rt h a to ft h e
control proteins (35.4%, P =3 . 3×1 0
–45). The second
cutoff (degree >12) was determined by the method in
Yu et al. [15], which selects the cutoff based on degree
distribution. According to this cutoff, there were 164
cancer proteins (48.0%) being classified into hubs. The
proportion was statistically higher than that of the
essential proteins (38.1%, c
2 test, P =7 . 3×1 0
–4)o rt h e
control proteins (16.6%, P =2 . 1×1 0
–49). On average, a
protein with high degree is approximately two times
more likely to be involved in cancer than in control.
These observations indicated that the cancer proteins
were more likely to be network hubs than the control
proteins or even the essential proteins.
Interestingly, comparing the essential proteins, the
cancer proteins had stronger connectivity and tended to
be hubs in the human interactome. This observation
might reflect that the cancer genes mainly play impor-
tant role in cell proliferation, cell differentiation and cell
death [1], or might be due to the data bias of the cancer
genes toward more studies, as cancer is the most stu-
died disease [4]. Our preliminary study using the homo-
logous genes in yeast and unbiased yeast protein-protein
interaction data revealed that this data bias is not the
primary factor for the cancer protein features and the
conclusion above could still hold in the yeast interac-
tome (data not shown). More work is needed to eluci-
date this difference.
Cancer proteins tend to have higher betweenness
Betweenness measures the number of shortest paths
through a node in a network. This measurement may
reflect the extent of signals that might have paths
through the node in a biological network. Among the
342 cancer proteins, 319 had betweenness greater than
zero. The average betweenness of the cancer proteins
(6.29 × 10
4) was significantly greater than that of the
essential proteins (4.16 × 10
4, Wilcoxon test, P =1 . 9×
10
–4) or that of the control proteins (1.47 × 10
4, P <2 . 2
×1 0
–16). Figure 2 shows the betweenness distributions
of the three protein sets. The pattern of betweenness
distributions was similar to that of the degree distribu-
tions for the three protein sets. The cancer proteins
tended to have higher betweenness compared to the
essential proteins or control proteins, reflecting that
there are more signals passing through the cancer
Figure 1 Degree distribution and average degrees of the
cancer, essential, and control proteins. Y-axis represents the
proportion of proteins having a specific degree. The average degree
of each protein set is labelled in vertical line. Red dots denote
cancer proteins, black dots denote essential proteins, and grey dots
denote control proteins.
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proteins.
Cancer proteins tend to have lower clustering coefficient
Clustering coefficient of a node of interest in a network
measures how well connected among its direct interac-
tors. A higher clustering coefficient of a node indicates
a higher density of its network connections. The average
clustering coefficient of the cancer proteins (0.13) was
almost equal to that of the essential proteins (0.14, Wil-
coxon test, P = 0.20) but was significantly lower than
that of the control proteins (0.19, P = 0.0024). To
explore specific features of clustering coefficients, we
separated clustering coefficients into different bins with
an interval of 0.1 and calculated the relative frequency
of proteins in each bin (Figure 3). We found that 69.8%
of the cancer proteins had their clustering coefficients
within the intervals (0-0.2] (excluding 0 but including
0.2). This compared to 35.8% of the control proteins or
60.0% of the essential proteins. Interestingly, when the
clustering coefficient was 0 or greater than 0.9, the con-
trol proteins had highest proportion but cancer proteins
had the lowest proportion among the three protein sets
(Figure 3). Overall, relative to the control proteins, the
neighbors of the cancer proteins had less likelihood to
connect each other.
Cancer proteins tend to have shorter shortest-path distance
The average general shortest-path distance (gSPD) of
the cancer proteins was 3.63, which was significantly
shorter than that of the essential proteins (3.76, Wil-
coxon test, P = 1.1 × 10
–6) or the control proteins (3.99,
P <2 . 2×1 0
–16). Figure 4A shows the distribution of
the general shortest- path distance for the cancer pro-
teins, essential proteins and control proteins. When the
distance was ≤ 3, the proportion of the cancer proteins
(44.9%) was larger than that of the essential proteins
( 3 7 . 9 % )o rt h a to ft h ec o n t r o lp r o t e i n s( 2 5 . 9 % ) .T h e
opposite pattern was observed when the distance was
>3. Therefore, the overall shorter average general short-
est-path distance for cancer proteins is primarily attribu-
ted to those cancer proteins whose gSPD distance is ≤ 3
in the comparison of the essential or control proteins.
Similarly, we found that the average characteristic short-
est-path distance (cSPD) of the cancer proteins (3.20) was
significantly shorter than that of the essential proteins
(3.55, Wilcoxon test, P < 2.2 × 10
–16) or that of the control
proteins (4.10, P < 2.2 × 10
–16) (Figure 4B). For the cancer
Figure 2 Betweenness distribution of the cancer, essential, and control proteins. Y-axis represents the proportion of proteins having a
specific betweenness. The average betweenness value of each protein set is labelled in vertical line. Red dots denote cancer proteins, black dots
denote essential proteins, and grey dots denote control proteins.
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than the average gSPDs (3.63) (P < 2.2 × 10
–16). Specifi-
cally, when distance equaled to 3, the proportion of the
cancer proteins for gSPD (38.3%) was much lower than
that of the cancer proteins for cSPD (51.3%). Conversely,
when distance equaled to 4, the proportion of the cancer
proteins for gSPD (42.2%) was much larger than that of
the cancer proteins for cSPD (28.5%). This comparison
indicates that the efficiency of cancer proteins contacting
with each other might be higher than that of cancer pro-
teins contacting with non-cancer proteins in the human
protein interaction network.
Strong positive correlation between degree and
betweenness of cancer proteins
Since betweenness measures the paths through a node
which has its degree of interactions in the network, it is
interesting to examine the correlation between degree and
betweenness for cancer proteins. Figure 5 plotted the
degree and betweenness for all cancer proteins. We found
the correlation between the degree and betweenness was
very strong (Pearson’s product-moment correlation test, r
=0 . 9 2 ,P < 2.2 × 10
–16). The result indicates that the num-
ber of the paths through a cancer protein in the human
interactome is highly correlated with its degree.
Weak negative correlation between degree and clustering
coefficient of the cancer proteins
Clustering coefficient is based on degree [26]. Similarly,
we examined the correlation between degree and clus-
tering coefficient for cancer proteins. The correlation
coefficient (r) was -0.14 (Pearson’s product-moment cor-
relation test, P = 0.01) between these two measure-
ments. This negative correlation confirms our previous
observation that, although cancer proteins themselves
have high connectivity, relative to other proteins and
cancer proteins’ degree, their neighbors do not have
high density of clusters (Table 1).
Global properties of the recessive and dominant cancer
proteins
Among the 72 recessive and 310 dominant cancer genes,
69 and 310 whose proteins could be mapped into the
Figure 3 Distribution of clustering coefficients of the cancer, essential, and control proteins.
Figure 4 Distribution of the shortest-path distance of the
cancer, essential, and control proteins. (A) General shortest-path
distance (gSPD) between nodes of interest and the rest of nodes in
the whole network. (B) Characteristic shortest-path distance (cSPD)
between a pair of nodes from the same protein set.
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bal properties. The results were summarized in Table 1.
For average degree, average clustering coefficient and
general shortest-path distance (gSPD), no significant dif-
ference was detected between the recessive and domi-
nant cancer proteins. The average degree of the
recessive cancer proteins (33.03) was higher than that of
recessive cancer proteins (23.44). Although the average
degree was not significantly different between these two
cancer protein sets (Wilcoxon test, P = 0.11), we found
that their degree distributions were significantly different
(Wilcoxon test, P =3 . 1×1 0
–8). Moreover, the average
betweenness (9.82 × 10
4) of the recessive cancer pro-
teins was higher than that of the dominant cancer pro-
teins (5.33 × 10
4, Wilcoxon test, P = 0.049). Finally, the
average cSPD of the recessive cancer proteins (3.05) was
significantly lower than that of the dominant cancer
proteins (3.21, Wilcoxon test, P <2 . 2×1 0
–16). These
comparisons revealed that recessive cancer proteins
have even stronger network topological properties, sug-
gesting different inheritable mechanisms of the recessive
and dominant cancer genes in cancer.
Nonrandomness of cancer-specific subnetworks
To gain further insight into the organization and envir-
onment of the cancer proteins, we extracted cancer spe-
cific subnetworks from the human interactome. These
subnetworks included all protein-protein interactions
between the cancer proteins. We did not include any
other non- cancer proteins because the network would
be otherwise too large. Among the 342 cancer proteins,
254 (74.3%) had direct links (a total of 595 direct links).
Among these 254 cancer proteins, 240 could form a
large subnetwork while the other 14 proteins formed 6
small subnetworks. Figure 6 displays these subnetworks
with two different types of cancer proteins being
marked: recessive cancer proteins in red and dominant
cancer proteins in blue. In the cancer-specific networks,
the average connectivity was 4.69, the average general
shortest-path distance was 3.57 and the average cluster-
ing coefficient was 0.20.
We next assessed whether the cancer-specific subnet-
works are non-random. We generated 1000 random
subnetworks with the same number of nodes and links
in the cancer-specific networks, and then compared
their average degree, average shortest-path distance and
average clustering coefficient. Among the 254 nodes in
cancer specific subnetworks, 62 (22.4%) had high con-
nectivity (degree > 5), while among the 254,000 nodes
in the 1000 random subnetworks, only 0.2% of the
nodes had high connectivity (degree > 5). Among 1000
random networks, the average shortest-path distance
was 3.71 and the average clustering coefficient was 0.02.
The empirical P values for shortest-path distance and
clustering coefficient were zero. This evaluation revealed
that the cancer-specific networks are not random.
It is worth noting that, in the cancer subnetworks,
several cancer proteins are critical in the network topol-
ogy: BRCA1, EP300, PIK3R1 and TP53. All of them are
recessive cancer proteins. When we removed them from
the cancer-specific network, the network centralization
decreased from 0.141 to 0.126. Here, network
Figure 5 Significant correlation between degree and betweenness of the cancer proteins.
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removing some central nodes in the whole network [32].
The result indicates that after removing the four pro-
teins from the cancer-specific network, the cancer-speci-
fic network become much looser. This network feature
supports the experimental evidence of these genes being
critical in the pathology of cancer.
Pathways enriched in top cancer proteins
Based on the comparison of the basic network proper-
ties among cancer proteins, essential proteins and con-
trol proteins, we selected the top 20 cancer proteins for
each network measurement (connectivity, betweenness,
clustering coefficient, gSPD and cSPD). This resulted in
a total of 44 non-redundant cancer proteins. The strong
overlap of top cancer proteins among these five network
measurements suggests that these network properties
are effective in detecting cancer protein features.
To examine functional features of these top cancer
genes, we performed pathway enrichment analysis using
KEGG data [29] (see Methods). We identified 24 path-
ways that were significantly enriched with the 44 top
cancer genes (Fisher’se x a c tt e s t ,F D RP < 0.001). These
pathways were listed in Table 2. Among these 24 path-
ways, 13 (54.2%) were directly related to cancer while
the remaining ones were related to cell cycle/division,
adhesion and signaling, which are also related to cancer.
It is worthy noting that all these 13 pathways were
ranked in the top 15 of the pathways ranked by FDR P
values. Among the remaining 11 pathways, 7 were
Figure 6 Cancer-specific subnetworks extracted from the human interactome based on their direct interactions. Recessive cancer
proteins are labelled in red and dominant cancer proteins in blue. Two hundreds and forty cancer proteins could form a large network while
the remaining 14 cancer proteins formed six small networks.
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KEGG PATHWAY database [30]. They were related to
the biological processes such as sustained angiogenesis,
evading apoptosis and proliferation, which are central
processes of tumorigenesis [3 3 ] .T h i sa n a l y s i si n d i c a t e s
that the cancer genes populate cellular pathways that
control cellular proliferation and cell death [34]. In sum-
mary, functional features of the top cancer genes sup-
port that pathology of cancer is a dynamic process
caused by dysregulation of multiple pathways.
Conclusion
In this study, we explored the global characteristics of
cancer proteins in the human protein- protein interac-
tion network. Based on the four topological measure-
ments, we found that the cancer proteins had
significantly different topological properties compared to
the essential or control proteins. Specifically, cancer pro-
teins tended to have higher connectivity and between-
ness, shorter shortest-path distance, and weaker
clustering coefficient than other proteins. We also found
recessive cancer proteins had even stronger network
characteristics than dominant cancer proteins. Our
results suggest that protein-protein interaction features
of cancer genes are important for our understanding the
etiology of cancers and, potentially, for other complex
diseases.
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Table 2 Pathways significantly enriched in the top cancer proteins ranked by network properties
Ranking KEGG entry Pathway name No. of gene
a P value
b FDR P value
c
1 hsa05215 Prostate cancer 15 1.8 × 10
–19 4.5 × 10
–18
2 hsa05220 Chronic myeloid leukemia 12 1.3 × 10
–15 1.6 × 10
–14
3 hsa05219 Bladder cancer 9 1.3 × 10
–13 1.1 × 10
–12
4 hsa05213 Endometrial cancer 9 1.3 × 10
–12 8.4 × 10
–12
5 hsa05223 Non-small cell lung cancer 8 8.2 × 10
–11 4.1 × 10
–10
6 hsa05210 Colorectal cancer 9 2.0 × 10
–10 8.4 × 10
–10
7 hsa05214 Glioma 8 4.6 × 10
–10 1.7 × 10
–9
8 hsa05216 Thyroid cancer 6 8.1 × 10
–10 2.5 × 10
–9
9 hsa05218 Melanoma 8 1.0 × 10
–9 2.9 × 10
–9
10 hsa05212 Pancreatic cancer 8 1.2 × 10
–9 3.0 × 10
–9
11 hsa05221 Acute myeloid leukemia 7 4.4 × 10
–9 1.0 × 10
–8
12 hsa04012 ErbB signaling pathway 8 6.7 × 10
–9 1.4 × 10
–8
13 hsa05211 Renal cell carcinoma 7 2.1 × 10
–8 4.0 × 10
–8
14 hsa04110 Cell cycle 8 1.1 × 10
–7 1.9 × 10
–7
15 hsa05222 Small cell lung cancer 7 1.2 × 10
–7 2.0 × 10
–7
16 hsa04630 Jak-STAT signaling pathway 8 1.0 × 10
–6 1.6 × 10
–6
17 hsa04520 Adherens junction 6 1.1 × 10
–6 1.6 × 10
–6
18 hsa04916 Melanogenesis 6 6.6 × 10
–6 9.1 × 10
–6
19 hsa04310 Wnt signaling pathway 7 9.6 × 10
–6 1.3 × 10
–5
20 hsa04660 T cell receptor signaling pathway 5 4.9 × 10
–5 6.2 × 10
–5
21 hsa04510 Focal adhesion 7 7.8 × 10
–5 9.3 × 10
–5
22 hsa04650 Natural killer cell mediated cytotoxicity 5 3.7 × 10
–4 4.2 × 10
–4
23 hsa04120 Ubiquitin mediated proteolysis 5 4.0 × 10
–4 4.3 × 10
–4
24 hsa04010 MAPK signaling pathway 7 5.6 × 10
–4 5.9 × 10
–4
aNumber of genes in the 44 cancer protein set that could be found in KEGG pathways.
bP values were calculated by the Fisher’s exact test.
cFDR P values were calculated using Benjamini-Hochberg procedure.
Sun and Zhao BMC Genomics 2010, 11(Suppl 3):S5
http://www.biomedcentral.com/1471-2164/11/S3/S5
Page 9 of 10Competing interests
The authors declare that they have no competing interests.
Published: 1 December 2010
References
1. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N,
Stratton MR: A census of human cancer genes. Nat Rev Cancer 2004,
4:177-183.
2. Cancer Gene Census. [http://www.sanger.ac.uk/genetics/CGP/Census/].
3. Jonsson PF, Bates PA: Global topological features of cancer proteins in
the human interactome. Bioinformatics 2006, 22:2291-2297.
4. Ideker T, Sharan R: Protein networks in disease. Genome Res 2008,
18:644-65.
5. Oti M, Snel B, Huynen MA, Brunner HG: Predicting disease genes using
protein- protein interactions. J Med Genet 2006, 43:691-698.
6. Feldman I, Rzhetsky A, Vitkup D: Network properties of genes harboring
inherited disease mutations. Proc Natl Acad Sci U S A 2008, 105:4323-4328.
7. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL: The human
disease network. Proc Natl Acad Sci U S A 2007, 104:8685-8690.
8. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO,
Brownstein BH, Cobb JP, Tschoeke SK, et al: A network-based analysis of
systemic inflammation in humans. Nature 2005, 437:1032-1037.
9. Sun J, Jia P, Fanous AH, Webb BT, van den Oord EJCG, Kendler KS, Zhao Z:
A multi-dimensional evidence-based candidate gene prioritization
approach for complex diseases. Bioinformatics 2009, 25:2595-2602.
10. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z: The dystrobrevin
binding protein 1 (DTNBP1) gene: features and networks. Mol Psychiatry
2009, 14:18-29.
11. Platzer A, Perco P, Lukas A, Mayer B: Characterization of protein-
interaction networks in tumors. BMC Bioinformatics 2007, 8:224.
12. Aragues R, Sander C, Oliva B: Predicting cancer involvement of genes
from heterogeneous data. BMC Bioinformatics 2008, 9:172.
13. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S,
Pawson T, Morris Q, Wrana JL: Dynamic modularity in protein interaction
networks predicts breast cancer outcome. Nat Biotechnol 2009,
27:199-204.
14. Jeong H, Mason SP, Barabasi AL, Oltvai ZN: Lethality and centrality in
protein networks. Nature 2001, 411:41-42.
15. Yu H, Greenbaum D, Xin Lu H, Zhu X, Gerstein M: Genomic analysis of
essentiality within protein networks. Trends Genet 2004, 20:227-231.
16. Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK,
Surendranath V, Niranjan V, Muthusamy B, Gandhi TK, Gronborg M, et al:
Development of human protein reference database as an initial
platform for approaching systems biology in humans. Genome Res 2003,
13:2363-2371.
17. Bader GD, Donaldson I, Wolting C, Ouellette BF, Pawson T, Hogue CW:
BIND–The Biomolecular Interaction Network Database. Nucleic Acids Res
2001, 29:242-245.
18. Hermjakob H, Montecchi-Palazzi L, Lewington C, Mudali S, Kerrien S,
Orchard S, Vingron M, Roechert B, Roepstorff P, Valencia A, et al: IntAct: an
open source molecular interaction database. Nucleic Acids Res 2004, 32:
D452-455.
19. Zanzoni A, Montecchi-Palazzi L, Quondam M, Ausiello G, Helmer-
Citterich M, Cesareni G: MINT: a Molecular INTeraction database. FEBS Lett
2002, 513:135-140.
20. Joshi-Tope G, Gillespie M, Vastrik I, D’Eustachio P, Schmidt E, de Bono B,
Jassal B, Gopinath GR, Wu GR, Matthews L, et al: Reactome: a
knowledgebase of biological pathways. Nucleic Acids Res 2005, 33:
D428-432.
21. Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU, Eisenberg D: The
Database of Interacting Proteins: 2004 update. Nucleic Acids Res 2004, 32:
D449-451.
22. NCBI. [http://www.ncbi.nlm.nih.gov/].
23. Volinia S, Mascellani N, Marchesini J, Veronese A, Ormondroyd E, Alder H,
Palatini J, Negrini M, Croce CM: Genome wide identification of recessive
cancer genes by combinatorial mutation analysis. PLoS ONE 2008, 3:
e3380.
24. Blake JA, Eppig JT, Bult CJ, Kadin JA, Richardson JE: The Mouse Genome
Database (MGD): updates and enhancements. Nucleic Acids Res 2006, 34:
D562-567.
25. Mouse Genome Informatics. [http://www.informatics.jax.org/].
26. Barabasi AL, Oltvai ZN: Network biology: understanding the cell’s
functional organization. Nat Rev Genet 2004, 5:101-113.
27. Albert R, Jeong H, Barabasi AL: Error and attack tolerance of complex
networks. Nature 2000, 406:378-382.
28. Erdős P, Rényi A: On the evolution of random graphs. Publ Math Inst
Hung Acad Sci 1960, 5:17-60.
29. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T,
Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y: KEGG for linking
genomes to life and the environment. Nucleic Acids Res 2008, 36:
D480-484.
30. KEGG PATHWAY. [http://www.genome.jp/kegg/pathway.html].
31. Benjamini Y, Hochberg Y: Controlling the False Discovery Rate: a Practical
and Powerful Approach to Multiple Testing. JR Statist Soc B 1995,
57:289-300.
32. Dong J, Horvath S: Understanding network concepts in modules. BMC
Syst Biol 2007, 1:24.
33. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70.
34. Bunz F: Principles of cancer genetics. New York: Springer; 2008.
doi:10.1186/1471-2164-11-S3-S5
Cite this article as: Sun and Zhao: A comparative study of cancer
proteins in the human protein-protein interaction network. BMC
Genomics 2010 11(Suppl 3):S5.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sun and Zhao BMC Genomics 2010, 11(Suppl 3):S5
http://www.biomedcentral.com/1471-2164/11/S3/S5
Page 10 of 10